<DOC>
	<DOCNO>NCT01206478</DOCNO>
	<brief_summary>Gastrojejunal ( G-J ) feed tube place infant child refuse eat unable eat enough normal growth . Although often intend temporary short-term solution medical complication , feed tube become permanent method eating . While tube feed routinely save life child long term food refusal , continuation tube feed hard patient , caregiver , family . At current time treatment help child move tube oral feeding . Some patient may treat help inpatient program combination medical behavioral technique train child eat orally . These program typically require hospital stay 2-4 month . By current study investigator hope learn investigational drug amitriptyline helpful move child tube oral feeding , look whether treatment pain help transition .</brief_summary>
	<brief_title>Trial Amitriptyline Chronic Oral Food Refusal Children 9 Months 8 Years Age</brief_title>
	<detailed_description>This research study involve study drug call amitriptyline megestrol . Amitriptyline might help child feed problem pain megestrol known increase appetite . Amitriptyline megestrol liquid syrups give feed tube daily . Amitriptyline approve United States Food Drug Administration ( FDA ) treatment child feed problem . Amitriptyline investigational drug study find side effect , whether product work child feed problem . Amitriptyline approve FDA treatment depression . Megestrol approve United States Food Drug Administration ( FDA ) treatment child feed problem . Megestrol investigational drug study find side effect , whether product work child feed problem . Megestrol approve FDA treatment adult . Though megestrol FDA approve treat child feed problem , often use purpose . Megestrol Amitriptyline affect nerve cell carry pain sensation brain . Both drug reduce intensity pain signal go part brain feel pain . Each drug attach nerve cell separate spot nerve cell pain well manage .</detailed_description>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Inclusion Criteria Subjects must meet follow inclusion criterion : 1 . Males females 9 month 8 year 0 month 0 day age . 2 . Able obtain parental legal guardian write informed consent subject applicable local law regulation . 3 . Subjects must possess oral motor skill necessary eat accord Table 1 Appendix . 4 . Subjects must possess behavioral skill necessary mealtime accord Table 2 Appendix . 5 . Subjects must history chronic oral food refusal ( 3 month refuse eat 5 % caloric intake orally ) feed &gt; 95 % caloric intake gastrostomy tube 3 month longer . 6 . Subjects require body mass index age/gender 25 % great prior beginning protocol ensure subject sufficiently nourish . Exclusion Criteria Study enrollment exclude potential subject follow condition take follow medication : 1 . Children MAO inhibitor thyroid problem exclude . 2 . Children diabetes adrenal insufficiency exclude . 3 . Children known heart conduction abnormality . 4 . Children take tricyclic medication .</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>